VIVUS, Inc. Collaborates With Aetna To Test First Comprehensive Weight Management Program Integrating Weight Loss Medication

Published: Jan 14, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, Calif., Jan. 14, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), today announced that it has joined with Aetna (NYSE:AET), one of the nation's leading diversified health care benefits companies, to integrate Qsymia® (phentermine and topiramate extended-release) capsules CIV into a pilot program designed to evaluate the benefits of prescription medication combined with lifestyle support for weight loss. The program is the first of its kind involving Qsymia and a health care benefits provider.

Help employers find you! Check out all the jobs and post your resume.

Back to news